KI Intstitute





Karl L. Mettinger, MD, Ph.D. President & CEO



Cellastra has established meaningful collaborations with leading scientists/research institutions in Sweden and the U.S. We are very interested in learning more about your work in related areas as we aim to drive the movement of promising discoveries from the lab to the clinic and ultimately to patients.


Today’s drug development advances require vast resources and input from many areas. Cellastra welcomes collaboration with industry partners possessing complimentary technologies and interests.

With its headquarters in San Francisco, Cellastra is in an advantageous position to apply for grants and loans from California Institute of Regenerative Medicine (CIRM), the world’s largest funding agency for stem cell research and development of therapeutics for unmet medical needs.